A. Gherman, C. Căinap, A.-M. Constantin, S. Cetean, and S. S. Căinap, “Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab”, Med Pharm Rep, vol. 90, no. 4, pp. 377–384, Oct. 2017.